Ticker Scorecard - INNV Basics Company: Innovus Pharmaceuticals Inc IPO Date: March 4, 2021 Sector: Healthcare Industry: Medical Care Facilities Market Cap: $549.95M Activated in VL: True Average Daily Range Avg Daily Range: $0.22 | 3.09% Avg Daily Range (30 D): $0.12 | 3.11% Avg Daily Range (90 D): $0.13 | 2.59% Institutional Daily Volume Avg Daily Volume: .16M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .03M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 54 Avg Trade Size (Sh.) (90 D): 55 Institutional Trades Total Inst.Trades: 115 Avg Inst. Trade: $2.5M Avg Inst. Trade (30 D): $.67M Avg Inst. Trade (90 D): $.67M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.86M Avg Closing Trade (30 D): $.67M Avg Closing Trade (90 D): $.67M Avg Closing Volume: 246.33K     News Aug 22, 2024 @ 7:20 PM CORRECTION -- InnovAge PACE Celebrates Anniversary... Source: Clear® Verified Jun 10, 2024 @ 12:00 PM InnovAge Holding Corp. Announces $5.0 Million Shar... Source: InnovAge Jun 3, 2024 @ 12:05 PM InnovAge PACE Recertified as a Great Place to Work... Source: InnovAge May 29, 2024 @ 5:05 PM InnovAge Celebrates Grand Opening of Orlandoâ€â... Source: InnovAge May 20, 2024 @ 12:00 PM InnovAge Welcomes John Koehn as Senior Vice Presid... Source: InnovAge Financials   TTM Q1 2025 Q4 2024 Basic EPS $-.13 $-.04 $-.02 Diluted EPS $-.13 $-.04 $-.02 Revenue $ 786.51M $ 205.14M $ 199.4M Gross Profit $ 138.73M $ 34.54M $ 36.58M Net Income / Loss $ -17.97M $ -5.71M $ -2.25M Operating Income / Loss $ -17.36M $ -4.9M $ -4.88M Cost of Revenue $ 236.92M $ 63.39M $ 60.13M Net Cash Flow $ -49.38M $ -17.93M $ 2.85M PE Ratio     Splits Mar 18, 2019:   105:1